Cargando…
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood
Recurrence of hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) after liver transplant (LT) is mediated by circulating tumour cells (CTCs) and exacerbated by the immunosuppressants required to prevent graft rejection. To circumvent the effects of immunosuppressants, we developed immunosup...
Autores principales: | Lin, Meiyin, Bhakdi, Sebastian Chakrit, Tan, Damien, Lee, Joycelyn Jie Xin, Tai, David Wai Meng, Pavesi, Andrea, Wai, Lu-En, Wang, Tina, Bertoletti, Antonio, Tan, Anthony Tanoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460197/ https://www.ncbi.nlm.nih.gov/pubmed/37636242 http://dx.doi.org/10.1093/immadv/ltad015 |
Ejemplares similares
-
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021) -
Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021) -
Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions
por: Healy, Katie, et al.
Publicado: (2021) -
The Armour Skeleton
por: Fothergill, W. E.
Publicado: (1887) -
Challenges of CAR- and TCR-T cell–based therapy for chronic infections
por: Bertoletti, Antonio, et al.
Publicado: (2020)